Review



ep300 activity  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress ep300 activity
    ZCWPW2 binds to H3K4me3-mediated promoter regions in independence of PRDM9. ( A ) Schematic summary illustrating that ZCWPW2 binds strongly to H3K4me3-marked promoter regions both in the absence and presence of PRDM9. ( B ) GO analysis of genes marked by ZCWPW2 peaks at promoter-associated H3K4me3 sites in HEK293T cells. ( C ) CUT&Tag tracks display ZCWPW2 (W2) binding peaks at promoter regions of genes implicated in DNA repair (e.g. RAD51AP1, RAD51C, MRE11, ATM, BARD1, ZCWPW1 ) and chromosome segregation (e.g. SMC2, RAD21, ANKRD31 ), as well as lactylation modification (e.g. <t>EP300</t> ). IgG was used as a negative control. ( D ) Confirmation of ZCWPW2 (W2) binding at key genes’ promoter regions by PCR amplification using primers targeting the promoter regions. IgG served as a negative control. ( E ) Relative enrichment of ZCWPW2 binding chromatin fragments was measured by qPCR using primers targeting the promoter regions ( n = 3 independent experiments; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( F ) Relative luciferase activity driven by promoter fragments of RAD51C, RAD51AP1, RAD21, ZCWPW1, MRE11, BARD1, EP300, ANKRD31, SMC2 , and ATM in HEK293T cells co-transfected with increasing amounts of Flag- ZCWPW2 (ZCWPW2-OE, + and ++), compared to the control (empty vector) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( G ) qPCR analysis showing significant downregulation of Rad51c1, Rad51ap1, Rad21, Zcwpw1, Mre11a, Brd1, Ep300, Ankrd31, Smc2 , and Atm mRNA in testes from adult Zcwpw2 KO mice compared to WT mice ( n = 3 biologically independent WT mice and KO mice; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( H ) Bar graphs showing relative mRNA expression levels of key meiosis-related genes in testicular biopsies from the ZCWPW2 mutant patient compared to controls ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).
    Ep300 Activity, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p300+activator/p300+Antibody/pmc12828234-94-2-11
    Average 95 stars, based on 18 article reviews
    ep300 activity - by Bioz Stars, 2026-09
    95/100 stars

    Images

    1) Product Images from "A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice"

    Article Title: A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gkag049

    ZCWPW2 binds to H3K4me3-mediated promoter regions in independence of PRDM9. ( A ) Schematic summary illustrating that ZCWPW2 binds strongly to H3K4me3-marked promoter regions both in the absence and presence of PRDM9. ( B ) GO analysis of genes marked by ZCWPW2 peaks at promoter-associated H3K4me3 sites in HEK293T cells. ( C ) CUT&Tag tracks display ZCWPW2 (W2) binding peaks at promoter regions of genes implicated in DNA repair (e.g. RAD51AP1, RAD51C, MRE11, ATM, BARD1, ZCWPW1 ) and chromosome segregation (e.g. SMC2, RAD21, ANKRD31 ), as well as lactylation modification (e.g. EP300 ). IgG was used as a negative control. ( D ) Confirmation of ZCWPW2 (W2) binding at key genes’ promoter regions by PCR amplification using primers targeting the promoter regions. IgG served as a negative control. ( E ) Relative enrichment of ZCWPW2 binding chromatin fragments was measured by qPCR using primers targeting the promoter regions ( n = 3 independent experiments; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( F ) Relative luciferase activity driven by promoter fragments of RAD51C, RAD51AP1, RAD21, ZCWPW1, MRE11, BARD1, EP300, ANKRD31, SMC2 , and ATM in HEK293T cells co-transfected with increasing amounts of Flag- ZCWPW2 (ZCWPW2-OE, + and ++), compared to the control (empty vector) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( G ) qPCR analysis showing significant downregulation of Rad51c1, Rad51ap1, Rad21, Zcwpw1, Mre11a, Brd1, Ep300, Ankrd31, Smc2 , and Atm mRNA in testes from adult Zcwpw2 KO mice compared to WT mice ( n = 3 biologically independent WT mice and KO mice; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( H ) Bar graphs showing relative mRNA expression levels of key meiosis-related genes in testicular biopsies from the ZCWPW2 mutant patient compared to controls ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).
    Figure Legend Snippet: ZCWPW2 binds to H3K4me3-mediated promoter regions in independence of PRDM9. ( A ) Schematic summary illustrating that ZCWPW2 binds strongly to H3K4me3-marked promoter regions both in the absence and presence of PRDM9. ( B ) GO analysis of genes marked by ZCWPW2 peaks at promoter-associated H3K4me3 sites in HEK293T cells. ( C ) CUT&Tag tracks display ZCWPW2 (W2) binding peaks at promoter regions of genes implicated in DNA repair (e.g. RAD51AP1, RAD51C, MRE11, ATM, BARD1, ZCWPW1 ) and chromosome segregation (e.g. SMC2, RAD21, ANKRD31 ), as well as lactylation modification (e.g. EP300 ). IgG was used as a negative control. ( D ) Confirmation of ZCWPW2 (W2) binding at key genes’ promoter regions by PCR amplification using primers targeting the promoter regions. IgG served as a negative control. ( E ) Relative enrichment of ZCWPW2 binding chromatin fragments was measured by qPCR using primers targeting the promoter regions ( n = 3 independent experiments; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( F ) Relative luciferase activity driven by promoter fragments of RAD51C, RAD51AP1, RAD21, ZCWPW1, MRE11, BARD1, EP300, ANKRD31, SMC2 , and ATM in HEK293T cells co-transfected with increasing amounts of Flag- ZCWPW2 (ZCWPW2-OE, + and ++), compared to the control (empty vector) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( G ) qPCR analysis showing significant downregulation of Rad51c1, Rad51ap1, Rad21, Zcwpw1, Mre11a, Brd1, Ep300, Ankrd31, Smc2 , and Atm mRNA in testes from adult Zcwpw2 KO mice compared to WT mice ( n = 3 biologically independent WT mice and KO mice; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( H ) Bar graphs showing relative mRNA expression levels of key meiosis-related genes in testicular biopsies from the ZCWPW2 mutant patient compared to controls ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).

    Techniques Used: Binding Assay, Modification, Negative Control, Amplification, Two Tailed Test, Luciferase, Activity Assay, Transfection, Control, Plasmid Preparation, Expressing, Mutagenesis

    ZCWPW2 promotes lactylation and stability of recombination-associated proteins through coordination with ZCWPW1 in cultured cells. ( A ) Co-IP analysis of HEK293T cells overexpressed with HA-recombination-associated proteins (HSPA2, SYCP1, and MDC1) and Flag-ZCWPW2, with or without Myc-ZCWPW1, and in the presence or absence of siRNA targeting ZCWPW1 . Bar graph quantifies Kla signal intensity for each condition ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( B ) Co-IP analysis (left) for Kla of endogenous Mdc1, Hspa2, and Sycp1 in GC-2 cells after individual or combined knockdown of Zcwpw1 or/and Zcwpw2 using siRNAs. Quantification of Kla levels (right) showed a significant decrease in Kla upon Zcwpw1 or Zcwpw2 knockdown, with the greatest reduction observed upon dual silencing ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( C and D ) Co-IP (left) and quantification analysis (right) of Kla on endogenous Mdc1, Hspa2, and Sycp1 in GC-2 cells treated with the EP300 inhibitor A-485, the LDHA inhibitor sodium oxamate, or both (C), and with EP300 activator CTPB or exogenous lactate (D) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).
    Figure Legend Snippet: ZCWPW2 promotes lactylation and stability of recombination-associated proteins through coordination with ZCWPW1 in cultured cells. ( A ) Co-IP analysis of HEK293T cells overexpressed with HA-recombination-associated proteins (HSPA2, SYCP1, and MDC1) and Flag-ZCWPW2, with or without Myc-ZCWPW1, and in the presence or absence of siRNA targeting ZCWPW1 . Bar graph quantifies Kla signal intensity for each condition ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( B ) Co-IP analysis (left) for Kla of endogenous Mdc1, Hspa2, and Sycp1 in GC-2 cells after individual or combined knockdown of Zcwpw1 or/and Zcwpw2 using siRNAs. Quantification of Kla levels (right) showed a significant decrease in Kla upon Zcwpw1 or Zcwpw2 knockdown, with the greatest reduction observed upon dual silencing ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( C and D ) Co-IP (left) and quantification analysis (right) of Kla on endogenous Mdc1, Hspa2, and Sycp1 in GC-2 cells treated with the EP300 inhibitor A-485, the LDHA inhibitor sodium oxamate, or both (C), and with EP300 activator CTPB or exogenous lactate (D) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).

    Techniques Used: Cell Culture, Co-Immunoprecipitation Assay, Two Tailed Test, Knockdown

    Proposed schema of PRMD9–ZCWPW1–ZCWPW2 system regulating recombination progression. During meiotic recombination, PRDM9 marks the dual histone methylation of H3K4me3 and H3K36me3 at nucleosomes to define recombination hotspots (i, ii), while ZCWPW1 acts as a reader by recognizing these modifications (iii). In this study, we revealed that ZCWPW2 shows enhanced enrichment at dual histone methylation sites in the presence of PRDM9 and forms a complex with ZCWPW1 to interact with recombination machinery-associated proteins at these sites. Additionally, the ZCWPW1–ZCWPW2 complex interacts with and stabilizes the enzymatic activity of lactate dehydrogenase LDHA, promoting local lactate production. In parallel, ZCWPW2 binds independently to H3K4me3-rich promoter regions, regulating the transcription of meiosis-related genes, as well as that of the lactylation writer EP300 to catalyze lactylation. These two coordinated actions further stabilize the recombination machinery via the lactylation pathway, thereby successfully facilitating DSB repair during recombination progression.
    Figure Legend Snippet: Proposed schema of PRMD9–ZCWPW1–ZCWPW2 system regulating recombination progression. During meiotic recombination, PRDM9 marks the dual histone methylation of H3K4me3 and H3K36me3 at nucleosomes to define recombination hotspots (i, ii), while ZCWPW1 acts as a reader by recognizing these modifications (iii). In this study, we revealed that ZCWPW2 shows enhanced enrichment at dual histone methylation sites in the presence of PRDM9 and forms a complex with ZCWPW1 to interact with recombination machinery-associated proteins at these sites. Additionally, the ZCWPW1–ZCWPW2 complex interacts with and stabilizes the enzymatic activity of lactate dehydrogenase LDHA, promoting local lactate production. In parallel, ZCWPW2 binds independently to H3K4me3-rich promoter regions, regulating the transcription of meiosis-related genes, as well as that of the lactylation writer EP300 to catalyze lactylation. These two coordinated actions further stabilize the recombination machinery via the lactylation pathway, thereby successfully facilitating DSB repair during recombination progression.

    Techniques Used: Methylation, Activity Assay

    Related Articles

    Modification:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Expressing:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Quantitative Proteomics:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Knockdown:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Activation Assay:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Inhibition:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Enzyme-linked Immunosorbent Assay:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Lactate Dehydrogenase Assay:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Control:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    RNA Sequencing:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    ChIP-sequencing:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Co-Immunoprecipitation Assay:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Quantitative RT-PCR:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an

    Immunoprecipitation:

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma
    Article Snippet: Experimental groupings were defined as follows: (1) sh-NC group, sh-p300#1 group, and sh-p300#2 group; (2) Control (Ctrl) group, Lactate group (CD8 + T cells treated with 20 mM sodium lactate for 24 h), Lactate + p300 inhibitor group (CD8 + T cells treated with 20 mM sodium lactate and 30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group.30 μM p300 inhibitor C646 for 24 h), Lactate + p300 activator group (CD8 + T cells treated with 20 mM sodium lactate and 100 μM p300 activator CTB for 24 h), Lactate + sh-NC group, and Lactate + sh-p300 group. ... The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Article Title: α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
    Article Snippet: cells were collected 48–72 h after transfection. .. LDHA inhibitor (Galloflavin; Cat#HY-W040118; 10 −5 M; 24 h), p300 inhibitor (C646; Cat#HY-13823; 10 −5 M; 24 h), p300 activator (CTB; Cat#HY-134964; 10 −4 M; 24 h) and NALA (Cat#HY-B2227B; 300 mM; 24 h) were obtained from MedChemExpress (USA). .. SIRT1 inhibitor (EX527; Cat#A4181; 10 −5 M; 24 h) an



    Similar Products

    95
    MedChemExpress ep300 activity
    ZCWPW2 binds to H3K4me3-mediated promoter regions in independence of PRDM9. ( A ) Schematic summary illustrating that ZCWPW2 binds strongly to H3K4me3-marked promoter regions both in the absence and presence of PRDM9. ( B ) GO analysis of genes marked by ZCWPW2 peaks at promoter-associated H3K4me3 sites in HEK293T cells. ( C ) CUT&Tag tracks display ZCWPW2 (W2) binding peaks at promoter regions of genes implicated in DNA repair (e.g. RAD51AP1, RAD51C, MRE11, ATM, BARD1, ZCWPW1 ) and chromosome segregation (e.g. SMC2, RAD21, ANKRD31 ), as well as lactylation modification (e.g. <t>EP300</t> ). IgG was used as a negative control. ( D ) Confirmation of ZCWPW2 (W2) binding at key genes’ promoter regions by PCR amplification using primers targeting the promoter regions. IgG served as a negative control. ( E ) Relative enrichment of ZCWPW2 binding chromatin fragments was measured by qPCR using primers targeting the promoter regions ( n = 3 independent experiments; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( F ) Relative luciferase activity driven by promoter fragments of RAD51C, RAD51AP1, RAD21, ZCWPW1, MRE11, BARD1, EP300, ANKRD31, SMC2 , and ATM in HEK293T cells co-transfected with increasing amounts of Flag- ZCWPW2 (ZCWPW2-OE, + and ++), compared to the control (empty vector) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( G ) qPCR analysis showing significant downregulation of Rad51c1, Rad51ap1, Rad21, Zcwpw1, Mre11a, Brd1, Ep300, Ankrd31, Smc2 , and Atm mRNA in testes from adult Zcwpw2 KO mice compared to WT mice ( n = 3 biologically independent WT mice and KO mice; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( H ) Bar graphs showing relative mRNA expression levels of key meiosis-related genes in testicular biopsies from the ZCWPW2 mutant patient compared to controls ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).
    Ep300 Activity, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p300+activator/p300+Antibody/pmc12828234-94-2-11
    Average 95 stars, based on 1 article reviews
    ep300 activity - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    MedChemExpress ctb
    ZCWPW2 binds to H3K4me3-mediated promoter regions in independence of PRDM9. ( A ) Schematic summary illustrating that ZCWPW2 binds strongly to H3K4me3-marked promoter regions both in the absence and presence of PRDM9. ( B ) GO analysis of genes marked by ZCWPW2 peaks at promoter-associated H3K4me3 sites in HEK293T cells. ( C ) CUT&Tag tracks display ZCWPW2 (W2) binding peaks at promoter regions of genes implicated in DNA repair (e.g. RAD51AP1, RAD51C, MRE11, ATM, BARD1, ZCWPW1 ) and chromosome segregation (e.g. SMC2, RAD21, ANKRD31 ), as well as lactylation modification (e.g. <t>EP300</t> ). IgG was used as a negative control. ( D ) Confirmation of ZCWPW2 (W2) binding at key genes’ promoter regions by PCR amplification using primers targeting the promoter regions. IgG served as a negative control. ( E ) Relative enrichment of ZCWPW2 binding chromatin fragments was measured by qPCR using primers targeting the promoter regions ( n = 3 independent experiments; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( F ) Relative luciferase activity driven by promoter fragments of RAD51C, RAD51AP1, RAD21, ZCWPW1, MRE11, BARD1, EP300, ANKRD31, SMC2 , and ATM in HEK293T cells co-transfected with increasing amounts of Flag- ZCWPW2 (ZCWPW2-OE, + and ++), compared to the control (empty vector) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( G ) qPCR analysis showing significant downregulation of Rad51c1, Rad51ap1, Rad21, Zcwpw1, Mre11a, Brd1, Ep300, Ankrd31, Smc2 , and Atm mRNA in testes from adult Zcwpw2 KO mice compared to WT mice ( n = 3 biologically independent WT mice and KO mice; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( H ) Bar graphs showing relative mRNA expression levels of key meiosis-related genes in testicular biopsies from the ZCWPW2 mutant patient compared to controls ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).
    Ctb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p300+activator/CTB/custom%40hy-134964%4041990904
    Average 94 stars, based on 1 article reviews
    ctb - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress p300 activator
    Bioinformatics Analysis Identifies Key Factors in Histone Lactylation Modification. Note: ( A ) Schematic workflow of bioinformatics analysis for identifying key factors; ( B ) Volcano plot of DEGs in tumor tissues and adjacent normal tissues from dataset GSE2685 (Normal = 8, Tumor = 22); ( C ) Heatmap showing the correlation of co-expression module genes with tumor and normal tissues, with each cell displaying the correlation coefficient and p -value; ( D ) Venn diagram illustrating the intersection of Blue module genes, DEGs, CD8 + T cell-related genes, and p300 differential expression; ( F ) The tSNE distribution map of EP300 in various cell types in the scRNA-seq data " width="250" height="auto" />
    P300 Activator, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p300+activator/CTB/pmc12895709-77-1-18
    Average 94 stars, based on 1 article reviews
    p300 activator - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    MedChemExpress p300 activator ctb
    Bioinformatics Analysis Identifies Key Factors in Histone Lactylation Modification. Note: ( A ) Schematic workflow of bioinformatics analysis for identifying key factors; ( B ) Volcano plot of DEGs in tumor tissues and adjacent normal tissues from dataset GSE2685 (Normal = 8, Tumor = 22); ( C ) Heatmap showing the correlation of co-expression module genes with tumor and normal tissues, with each cell displaying the correlation coefficient and p -value; ( D ) Venn diagram illustrating the intersection of Blue module genes, DEGs, CD8 + T cell-related genes, and p300 differential expression; ( F ) The tSNE distribution map of EP300 in various cell types in the scRNA-seq data " width="250" height="auto" />
    P300 Activator Ctb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p300+activator/Cholera+toxin+B+subunit%2C+from+vibrio+cholerae/pm41518395-99-24-29
    Average 93 stars, based on 1 article reviews
    p300 activator ctb - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    95
    MedChemExpress p300 activation
    Bioinformatics Analysis Identifies Key Factors in Histone Lactylation Modification. Note: ( A ) Schematic workflow of bioinformatics analysis for identifying key factors; ( B ) Volcano plot of DEGs in tumor tissues and adjacent normal tissues from dataset GSE2685 (Normal = 8, Tumor = 22); ( C ) Heatmap showing the correlation of co-expression module genes with tumor and normal tissues, with each cell displaying the correlation coefficient and p -value; ( D ) Venn diagram illustrating the intersection of Blue module genes, DEGs, CD8 + T cell-related genes, and p300 differential expression; ( F ) The tSNE distribution map of EP300 in various cell types in the scRNA-seq data " width="250" height="auto" />
    P300 Activation, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p300+activator/p300+Antibody/pm41275207-96-0-8
    Average 95 stars, based on 1 article reviews
    p300 activation - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    Addgene inc dcas9 p300 activation dcas9 p300 construct
    Bioinformatics Analysis Identifies Key Factors in Histone Lactylation Modification. Note: ( A ) Schematic workflow of bioinformatics analysis for identifying key factors; ( B ) Volcano plot of DEGs in tumor tissues and adjacent normal tissues from dataset GSE2685 (Normal = 8, Tumor = 22); ( C ) Heatmap showing the correlation of co-expression module genes with tumor and normal tissues, with each cell displaying the correlation coefficient and p -value; ( D ) Venn diagram illustrating the intersection of Blue module genes, DEGs, CD8 + T cell-related genes, and p300 differential expression; ( F ) The tSNE distribution map of EP300 in various cell types in the scRNA-seq data " width="250" height="auto" />
    Dcas9 P300 Activation Dcas9 P300 Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p300+activator/pLV-dCas9-p300-P2A-PuroR+(Plasmid+%2383889)/pmc12333230__BLOOD_BLD-2024-026664-mmc1-69-8-12
    Average 95 stars, based on 1 article reviews
    dcas9 p300 activation dcas9 p300 construct - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Hasegawa Co Ltd histone acetyltransferase activity of p300
    Bioinformatics Analysis Identifies Key Factors in Histone Lactylation Modification. Note: ( A ) Schematic workflow of bioinformatics analysis for identifying key factors; ( B ) Volcano plot of DEGs in tumor tissues and adjacent normal tissues from dataset GSE2685 (Normal = 8, Tumor = 22); ( C ) Heatmap showing the correlation of co-expression module genes with tumor and normal tissues, with each cell displaying the correlation coefficient and p -value; ( D ) Venn diagram illustrating the intersection of Blue module genes, DEGs, CD8 + T cell-related genes, and p300 differential expression; ( F ) The tSNE distribution map of EP300 in various cell types in the scRNA-seq data " width="250" height="auto" />
    Histone Acetyltransferase Activity Of P300, supplied by Hasegawa Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p300+activator/p300+protein/pm40619438-500-24-18
    Average 90 stars, based on 1 article reviews
    histone acetyltransferase activity of p300 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Active Motif p300 active motif 61401 antibody
    Bioinformatics Analysis Identifies Key Factors in Histone Lactylation Modification. Note: ( A ) Schematic workflow of bioinformatics analysis for identifying key factors; ( B ) Volcano plot of DEGs in tumor tissues and adjacent normal tissues from dataset GSE2685 (Normal = 8, Tumor = 22); ( C ) Heatmap showing the correlation of co-expression module genes with tumor and normal tissues, with each cell displaying the correlation coefficient and p -value; ( D ) Venn diagram illustrating the intersection of Blue module genes, DEGs, CD8 + T cell-related genes, and p300 differential expression; ( F ) The tSNE distribution map of EP300 in various cell types in the scRNA-seq data " width="250" height="auto" />
    P300 Active Motif 61401 Antibody, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p300+activator/p300+protein/pmc12049546__41467_2025_59504_MOESM2_ESM-57-0-1
    Average 90 stars, based on 1 article reviews
    p300 active motif 61401 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    ZCWPW2 binds to H3K4me3-mediated promoter regions in independence of PRDM9. ( A ) Schematic summary illustrating that ZCWPW2 binds strongly to H3K4me3-marked promoter regions both in the absence and presence of PRDM9. ( B ) GO analysis of genes marked by ZCWPW2 peaks at promoter-associated H3K4me3 sites in HEK293T cells. ( C ) CUT&Tag tracks display ZCWPW2 (W2) binding peaks at promoter regions of genes implicated in DNA repair (e.g. RAD51AP1, RAD51C, MRE11, ATM, BARD1, ZCWPW1 ) and chromosome segregation (e.g. SMC2, RAD21, ANKRD31 ), as well as lactylation modification (e.g. EP300 ). IgG was used as a negative control. ( D ) Confirmation of ZCWPW2 (W2) binding at key genes’ promoter regions by PCR amplification using primers targeting the promoter regions. IgG served as a negative control. ( E ) Relative enrichment of ZCWPW2 binding chromatin fragments was measured by qPCR using primers targeting the promoter regions ( n = 3 independent experiments; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( F ) Relative luciferase activity driven by promoter fragments of RAD51C, RAD51AP1, RAD21, ZCWPW1, MRE11, BARD1, EP300, ANKRD31, SMC2 , and ATM in HEK293T cells co-transfected with increasing amounts of Flag- ZCWPW2 (ZCWPW2-OE, + and ++), compared to the control (empty vector) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( G ) qPCR analysis showing significant downregulation of Rad51c1, Rad51ap1, Rad21, Zcwpw1, Mre11a, Brd1, Ep300, Ankrd31, Smc2 , and Atm mRNA in testes from adult Zcwpw2 KO mice compared to WT mice ( n = 3 biologically independent WT mice and KO mice; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( H ) Bar graphs showing relative mRNA expression levels of key meiosis-related genes in testicular biopsies from the ZCWPW2 mutant patient compared to controls ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).

    Journal: Nucleic Acids Research

    Article Title: A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice

    doi: 10.1093/nar/gkag049

    Figure Lengend Snippet: ZCWPW2 binds to H3K4me3-mediated promoter regions in independence of PRDM9. ( A ) Schematic summary illustrating that ZCWPW2 binds strongly to H3K4me3-marked promoter regions both in the absence and presence of PRDM9. ( B ) GO analysis of genes marked by ZCWPW2 peaks at promoter-associated H3K4me3 sites in HEK293T cells. ( C ) CUT&Tag tracks display ZCWPW2 (W2) binding peaks at promoter regions of genes implicated in DNA repair (e.g. RAD51AP1, RAD51C, MRE11, ATM, BARD1, ZCWPW1 ) and chromosome segregation (e.g. SMC2, RAD21, ANKRD31 ), as well as lactylation modification (e.g. EP300 ). IgG was used as a negative control. ( D ) Confirmation of ZCWPW2 (W2) binding at key genes’ promoter regions by PCR amplification using primers targeting the promoter regions. IgG served as a negative control. ( E ) Relative enrichment of ZCWPW2 binding chromatin fragments was measured by qPCR using primers targeting the promoter regions ( n = 3 independent experiments; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( F ) Relative luciferase activity driven by promoter fragments of RAD51C, RAD51AP1, RAD21, ZCWPW1, MRE11, BARD1, EP300, ANKRD31, SMC2 , and ATM in HEK293T cells co-transfected with increasing amounts of Flag- ZCWPW2 (ZCWPW2-OE, + and ++), compared to the control (empty vector) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( G ) qPCR analysis showing significant downregulation of Rad51c1, Rad51ap1, Rad21, Zcwpw1, Mre11a, Brd1, Ep300, Ankrd31, Smc2 , and Atm mRNA in testes from adult Zcwpw2 KO mice compared to WT mice ( n = 3 biologically independent WT mice and KO mice; Two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( H ) Bar graphs showing relative mRNA expression levels of key meiosis-related genes in testicular biopsies from the ZCWPW2 mutant patient compared to controls ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).

    Article Snippet: To activate EP300 activity, cells were treated with 5 μM CTPB (MedChemEpress, HY-124960) for 24 h [ ].

    Techniques: Binding Assay, Modification, Negative Control, Amplification, Two Tailed Test, Luciferase, Activity Assay, Transfection, Control, Plasmid Preparation, Expressing, Mutagenesis

    ZCWPW2 promotes lactylation and stability of recombination-associated proteins through coordination with ZCWPW1 in cultured cells. ( A ) Co-IP analysis of HEK293T cells overexpressed with HA-recombination-associated proteins (HSPA2, SYCP1, and MDC1) and Flag-ZCWPW2, with or without Myc-ZCWPW1, and in the presence or absence of siRNA targeting ZCWPW1 . Bar graph quantifies Kla signal intensity for each condition ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( B ) Co-IP analysis (left) for Kla of endogenous Mdc1, Hspa2, and Sycp1 in GC-2 cells after individual or combined knockdown of Zcwpw1 or/and Zcwpw2 using siRNAs. Quantification of Kla levels (right) showed a significant decrease in Kla upon Zcwpw1 or Zcwpw2 knockdown, with the greatest reduction observed upon dual silencing ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( C and D ) Co-IP (left) and quantification analysis (right) of Kla on endogenous Mdc1, Hspa2, and Sycp1 in GC-2 cells treated with the EP300 inhibitor A-485, the LDHA inhibitor sodium oxamate, or both (C), and with EP300 activator CTPB or exogenous lactate (D) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).

    Journal: Nucleic Acids Research

    Article Title: A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice

    doi: 10.1093/nar/gkag049

    Figure Lengend Snippet: ZCWPW2 promotes lactylation and stability of recombination-associated proteins through coordination with ZCWPW1 in cultured cells. ( A ) Co-IP analysis of HEK293T cells overexpressed with HA-recombination-associated proteins (HSPA2, SYCP1, and MDC1) and Flag-ZCWPW2, with or without Myc-ZCWPW1, and in the presence or absence of siRNA targeting ZCWPW1 . Bar graph quantifies Kla signal intensity for each condition ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( B ) Co-IP analysis (left) for Kla of endogenous Mdc1, Hspa2, and Sycp1 in GC-2 cells after individual or combined knockdown of Zcwpw1 or/and Zcwpw2 using siRNAs. Quantification of Kla levels (right) showed a significant decrease in Kla upon Zcwpw1 or Zcwpw2 knockdown, with the greatest reduction observed upon dual silencing ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.). ( C and D ) Co-IP (left) and quantification analysis (right) of Kla on endogenous Mdc1, Hspa2, and Sycp1 in GC-2 cells treated with the EP300 inhibitor A-485, the LDHA inhibitor sodium oxamate, or both (C), and with EP300 activator CTPB or exogenous lactate (D) ( n = 3 independent experiments; two-tailed Student’s t -test; * P < 0.05; error bars, s.e.m.).

    Article Snippet: To activate EP300 activity, cells were treated with 5 μM CTPB (MedChemEpress, HY-124960) for 24 h [ ].

    Techniques: Cell Culture, Co-Immunoprecipitation Assay, Two Tailed Test, Knockdown

    Proposed schema of PRMD9–ZCWPW1–ZCWPW2 system regulating recombination progression. During meiotic recombination, PRDM9 marks the dual histone methylation of H3K4me3 and H3K36me3 at nucleosomes to define recombination hotspots (i, ii), while ZCWPW1 acts as a reader by recognizing these modifications (iii). In this study, we revealed that ZCWPW2 shows enhanced enrichment at dual histone methylation sites in the presence of PRDM9 and forms a complex with ZCWPW1 to interact with recombination machinery-associated proteins at these sites. Additionally, the ZCWPW1–ZCWPW2 complex interacts with and stabilizes the enzymatic activity of lactate dehydrogenase LDHA, promoting local lactate production. In parallel, ZCWPW2 binds independently to H3K4me3-rich promoter regions, regulating the transcription of meiosis-related genes, as well as that of the lactylation writer EP300 to catalyze lactylation. These two coordinated actions further stabilize the recombination machinery via the lactylation pathway, thereby successfully facilitating DSB repair during recombination progression.

    Journal: Nucleic Acids Research

    Article Title: A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice

    doi: 10.1093/nar/gkag049

    Figure Lengend Snippet: Proposed schema of PRMD9–ZCWPW1–ZCWPW2 system regulating recombination progression. During meiotic recombination, PRDM9 marks the dual histone methylation of H3K4me3 and H3K36me3 at nucleosomes to define recombination hotspots (i, ii), while ZCWPW1 acts as a reader by recognizing these modifications (iii). In this study, we revealed that ZCWPW2 shows enhanced enrichment at dual histone methylation sites in the presence of PRDM9 and forms a complex with ZCWPW1 to interact with recombination machinery-associated proteins at these sites. Additionally, the ZCWPW1–ZCWPW2 complex interacts with and stabilizes the enzymatic activity of lactate dehydrogenase LDHA, promoting local lactate production. In parallel, ZCWPW2 binds independently to H3K4me3-rich promoter regions, regulating the transcription of meiosis-related genes, as well as that of the lactylation writer EP300 to catalyze lactylation. These two coordinated actions further stabilize the recombination machinery via the lactylation pathway, thereby successfully facilitating DSB repair during recombination progression.

    Article Snippet: To activate EP300 activity, cells were treated with 5 μM CTPB (MedChemEpress, HY-124960) for 24 h [ ].

    Techniques: Methylation, Activity Assay

    Bioinformatics Analysis Identifies Key Factors in Histone Lactylation Modification. Note: ( A ) Schematic workflow of bioinformatics analysis for identifying key factors; ( B ) Volcano plot of DEGs in tumor tissues and adjacent normal tissues from dataset GSE2685 (Normal = 8, Tumor = 22); ( C ) Heatmap showing the correlation of co-expression module genes with tumor and normal tissues, with each cell displaying the correlation coefficient and p -value; ( D ) Venn diagram illustrating the intersection of Blue module genes, DEGs, CD8 + T cell-related genes, and

    Journal: Journal of Nanobiotechnology

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma

    doi: 10.1186/s12951-025-03957-z

    Figure Lengend Snippet: Bioinformatics Analysis Identifies Key Factors in Histone Lactylation Modification. Note: ( A ) Schematic workflow of bioinformatics analysis for identifying key factors; ( B ) Volcano plot of DEGs in tumor tissues and adjacent normal tissues from dataset GSE2685 (Normal = 8, Tumor = 22); ( C ) Heatmap showing the correlation of co-expression module genes with tumor and normal tissues, with each cell displaying the correlation coefficient and p -value; ( D ) Venn diagram illustrating the intersection of Blue module genes, DEGs, CD8 + T cell-related genes, and "Histone lactylation"-related genes; ( E ) Box plot of p300 differential expression; ( F ) The tSNE distribution map of EP300 in various cell types in the scRNA-seq data

    Article Snippet: The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Techniques: Modification, Expressing, Quantitative Proteomics

    p300 Regulates Histone Lactylation in CD8 + T Cells. Note: ( A ) Schematic representation of the experimental design, showing the workflow for detecting CD8 + T cells treated with lactate, p300 inhibitors, or activators. ( B–C ) WB analysis of PKla levels in CD8 + T cells over time (B) and under varying lactate concentrations ( C ). ( D–E ) WB analysis of the time-dependent ( D ) and dose-dependent ( E ) changes in H3K18la and H3K9la expression in CD8 + T cells following lactate treatment. *** p < 0.001, ** p < 0.01, and * p < 0.05 compared to the 0-h or untreated lactate group. ( F ) WB analysis of H3K18la and H3K9la expression in CD8 + T cells following p300 knockdown, activation, or inhibition. ( G ) ELISA detection of IFN-γ levels in the supernatant of CD8 + T cells across different treatment groups. (H) FCM analysis of GZMB expression in CD8 + T cells. ( I ) FCM analysis of CD8 + T cell proliferation. ( J ) LDH release assay showing the cytotoxic effects of CD8 + T cells on MKN-45 and SNU1 cells. In panels ( F–J ), * p < 0.05, ** p < 0.01, and *** p < 0.001 compared to the control group; # p < 0.05, ## p < 0.01, and ### p < 0.001 compared to the Lactate group; & p < 0.01 compared to the Lactate + sh-NC group. All cell-based experiments were performed in triplicate

    Journal: Journal of Nanobiotechnology

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma

    doi: 10.1186/s12951-025-03957-z

    Figure Lengend Snippet: p300 Regulates Histone Lactylation in CD8 + T Cells. Note: ( A ) Schematic representation of the experimental design, showing the workflow for detecting CD8 + T cells treated with lactate, p300 inhibitors, or activators. ( B–C ) WB analysis of PKla levels in CD8 + T cells over time (B) and under varying lactate concentrations ( C ). ( D–E ) WB analysis of the time-dependent ( D ) and dose-dependent ( E ) changes in H3K18la and H3K9la expression in CD8 + T cells following lactate treatment. *** p < 0.001, ** p < 0.01, and * p < 0.05 compared to the 0-h or untreated lactate group. ( F ) WB analysis of H3K18la and H3K9la expression in CD8 + T cells following p300 knockdown, activation, or inhibition. ( G ) ELISA detection of IFN-γ levels in the supernatant of CD8 + T cells across different treatment groups. (H) FCM analysis of GZMB expression in CD8 + T cells. ( I ) FCM analysis of CD8 + T cell proliferation. ( J ) LDH release assay showing the cytotoxic effects of CD8 + T cells on MKN-45 and SNU1 cells. In panels ( F–J ), * p < 0.05, ** p < 0.01, and *** p < 0.001 compared to the control group; # p < 0.05, ## p < 0.01, and ### p < 0.001 compared to the Lactate group; & p < 0.01 compared to the Lactate + sh-NC group. All cell-based experiments were performed in triplicate

    Article Snippet: The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Techniques: Expressing, Knockdown, Activation Assay, Inhibition, Enzyme-linked Immunosorbent Assay, Lactate Dehydrogenase Assay, Control

    CD8a-NVEs@C646 Facilitates Histone Delactylation Modification in CD8 + T Cells. Note: ( A ) Schematic workflow of RNA-seq and ChIP-seq experiments for CD8 + T cells treated with CD8a-NVEs@C646; ( B–C ) ChIP-seq analysis showing signals at TSS regions in PBS-treated (n = 3) and CD8a-NVEs@C646-treated groups (n = 3); ( D ) RNA-seq volcano plot illustrating significantly upregulated and downregulated genes in the CD8a-NVEs@C646-treated group compared to PBS (n = 3); ( E ) Venn diagram of overlapping genes from ChIP-seq and RNA-seq analyses related to CD8 + T cells; ( F ) ChIP analysis of p300 and H3K18la enrichment at the PDCD1 promoter region; ( G ) The protein interaction between p300 and H3K18la was detected by co-IP assay; ( H ) RT-qPCR analysis of PDCD1 mRNA expression in CD8 + T cells following CD8a-NVEs@C646 treatment; ( I ) WB analysis of PDCD1 and H3K18la protein expression levels in CD8 + T cells treated with CD8a-NVEs@C646. * p < 0.05, *** p < 0.001 compared to the PBS or sh-NC group; experiments were conducted in triplicate

    Journal: Journal of Nanobiotechnology

    Article Title: CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma

    doi: 10.1186/s12951-025-03957-z

    Figure Lengend Snippet: CD8a-NVEs@C646 Facilitates Histone Delactylation Modification in CD8 + T Cells. Note: ( A ) Schematic workflow of RNA-seq and ChIP-seq experiments for CD8 + T cells treated with CD8a-NVEs@C646; ( B–C ) ChIP-seq analysis showing signals at TSS regions in PBS-treated (n = 3) and CD8a-NVEs@C646-treated groups (n = 3); ( D ) RNA-seq volcano plot illustrating significantly upregulated and downregulated genes in the CD8a-NVEs@C646-treated group compared to PBS (n = 3); ( E ) Venn diagram of overlapping genes from ChIP-seq and RNA-seq analyses related to CD8 + T cells; ( F ) ChIP analysis of p300 and H3K18la enrichment at the PDCD1 promoter region; ( G ) The protein interaction between p300 and H3K18la was detected by co-IP assay; ( H ) RT-qPCR analysis of PDCD1 mRNA expression in CD8 + T cells following CD8a-NVEs@C646 treatment; ( I ) WB analysis of PDCD1 and H3K18la protein expression levels in CD8 + T cells treated with CD8a-NVEs@C646. * p < 0.05, *** p < 0.001 compared to the PBS or sh-NC group; experiments were conducted in triplicate

    Article Snippet: The p300 activator (cholera toxin B subunit, CTB; HY-134964) and p300 inhibitor (C646; HY-13823) were both purchased from MCE (USA); (3) PBS + vector group, CD8a-NVEs@C646 + vector group, and CD8a-NVEs@C646 + PDCD1 group, all treated with 20 mM sodium lactate for 24 h, with CD8a-NVEs@C646 treatment for 48 h. Cells from all groups were harvested for downstream analysis.

    Techniques: Modification, RNA Sequencing, ChIP-sequencing, Co-Immunoprecipitation Assay, Quantitative RT-PCR, Expressing